Nalaganje...
Human lymphokine-activated killer cells develop syngeneic killing ability.
Lymphokine-activated killer (LAK)-cell therapy has emerged as a new strategy in designing protocols for the treatment of cancer. However, in its present clinical form, it has not fulfilled the early promise shown in murine models of human metastatic disease. In an attempt to gain understanding as to...
Shranjeno v:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
1989
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1385239/ https://ncbi.nlm.nih.gov/pubmed/2784783 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|